Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Myelodysplasia in childhood may be a polyclonal disease.
Tchernia G, Bader-Meunier B, Lavergne JM, Miélot F, Dommergues JP. Tchernia G, et al. Among authors: lavergne jm. Hematol Cell Ther. 1996 Aug;38(4):325-30. doi: 10.1007/s00282-996-0325-0. Hematol Cell Ther. 1996. PMID: 8891724 Review.
Refractory anaemia and mitochondrial cytopathy in childhood.
Bader-Meunier B, Rötig A, Mielot F, Lavergne JM, Croisille L, Rustin P, Landrieu P, Dommergues JP, Munnich A, Tchernia G. Bader-Meunier B, et al. Among authors: lavergne jm. Br J Haematol. 1994 Jun;87(2):381-5. doi: 10.1111/j.1365-2141.1994.tb04926.x. Br J Haematol. 1994. PMID: 7947282
A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
Stepanian A, Ribba AS, Lavergne JM, Fressinaud E, Juhan-Vague I, Mazurier C, Girma JP, Meyer D. Stepanian A, et al. Among authors: lavergne jm. Br J Haematol. 2003 Feb;120(4):643-51. doi: 10.1046/j.1365-2141.2003.04168.x. Br J Haematol. 2003. PMID: 12588351 Free article.
Deletion of alanine 2201 in the FVIII C2 domain results in mild hemophilia A by impairing FVIII binding to VWF and phospholipids and destroys a major FVIII antigenic determinant involved in inhibitor development.
d'Oiron R, Lavergne JM, Lavend'homme R, Benhida A, Bordet JC, Negrier C, Peerlinck K, Vermylen J, Saint-Remy JM, Jacquemin M. d'Oiron R, et al. Among authors: lavergne jm. Blood. 2004 Jan 1;103(1):155-7. doi: 10.1182/blood-2003-04-1321. Epub 2003 Sep 11. Blood. 2004. PMID: 12969981 Free article.
78 results